TD Cowen lowered the firm’s price target on Standard BioTools (LAB) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm said they reported a 9% sales beat with margins ahead and cost controls solid, though sales upside was largely timing-related.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LAB: